A new study indicates that African American people with multiple sclerosis have higher markers of humoral disease pathology than white people with multiple sclerosis. However, apparent differences in pathophysiology between ethnic groups cannot be fully interpreted without more comprehensive studies that examine the effects of social inequality on disease.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Telesford, K. M. et al. Understanding humoral immunity and multiple sclerosis severity in Black, and Latinx patients. Front. Immunol. 14, 1172993 (2023).
Telesford, K. M. et al. Black African and Latino/a identity correlates with increased plasmablasts in MS. Neurol. Neuroimmunol. Neuroinflamm. 7, e634 (2019).
Saidenberg, L. et al. Faster B-cell repletion after anti-CD20 infusion in Black patients compared to white patients with neurologic diseases. Mult. Scler. Relat. Disord. 63, 103830 (2022).
Rinker, J. R. II, Trinkaus, K., Naismith, R. T. & Cross, A. H. Higher IgG index found in African Americans versus Caucasians with multiple sclerosis. Neurology 69, 68–72 (2007).
da Gama, P. D. et al. Oligoclonal bands in cerebrospinal fluid of Black patients with multiple sclerosis. BioMed Res. Int. 2015, 217961 (2015).
Xue, H., Arbini, A. A., Melton, H. J. & Kister, I. African American patients with multiple sclerosis (MS) have higher proportions of CD19+ and CD20+ B-cell lineage cells in their cerebrospinal fluid than White MS patients. Mult. Scler. Relat. Disord. 79, 105047 (2023).
Lett, E., Asabor, E., Beltrán, S., Cannon, A. M. & Arah, O. A. Conceptualizing, contextualizing, and operationalizing race in quantitative health sciences research. Ann. Fam. Med. 20, 157–163 (2022).
Simons, R. L. et al. Discrimination, segregation, and chronic inflammation: testing the weathering explanation for the poor health of Black Americans. Dev. Psychol. 54, 1993–2006 (2018).
Amezcua, L., Rivera, V. M., Vazquez, T. C., Baezconde-Garbanati, L. & Langer-Gould, A. Health disparities, inequities, and social determinants of health in multiple sclerosis and related disorders in the US: a review. JAMA Neurol. 78, 1515–1524 (2021).
Marrie, R. A. et al. Enhancing diversity of clinical trial populations in multiple sclerosis. Mult. Scler. 29, 1174–1185 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Orlando, C.M., Amezcua, L. A tale of race and B cells in multiple sclerosis. Nat Rev Neurol 20, 5–6 (2024). https://doi.org/10.1038/s41582-023-00907-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-023-00907-x